Bullous eruption and elevated leukocyte alkaline phosphatase in the course of busulfan-treated chronic granulocytic leukemia.
D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood*; D001132:Arm / Q000473:pathology; D001768:Blister / Q000139:chemically induced*; D001856:Bone Marrow Examination; D002066:Busulfan / Q000009:adverse effects*; D004892:Erythema Multiforme / Q000139:chemically induced*; D006801:Humans; D007717:Knee / Q000473:pathology; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D007962:Leukocytes / Q000201:enzymology*; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D012877:Skin Manifestations
D000469:Alkaline Phosphatase; D002066:Busulfan; D011241:Prednisone